10x Genomics Price to Free Cash Flow Ratio 2018-2024 | TXG
Historical price to free cash flow ratio values for 10x Genomics (TXG) since 2018.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 10x Genomics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-01-07 | 15.53 | 71.30 | |
| 2024-09-30 | 22.58 | $0.22 | 103.67 |
| 2024-06-30 | 19.45 | $-0.27 | 0.00 |
| 2024-03-31 | 37.53 | $-0.63 | 0.00 |
| 2023-12-31 | 55.96 | $-0.54 | 0.00 |
| 2023-09-30 | 41.25 | $-0.96 | 0.00 |
| 2023-06-30 | 55.84 | $-1.02 | 0.00 |
| 2023-03-31 | 55.79 | $-1.09 | 0.00 |
| 2022-12-31 | 36.44 | $-1.45 | 0.00 |
| 2022-09-30 | 28.48 | $-1.42 | 0.00 |
| 2022-06-30 | 45.25 | $-1.44 | 0.00 |
| 2022-03-31 | 76.07 | $-1.15 | 0.00 |
| 2021-12-31 | 148.96 | $-1.11 | 0.00 |
| 2021-09-30 | 145.58 | $-2.41 | 0.00 |
| 2021-06-30 | 195.82 | $-2.54 | 0.00 |
| 2021-03-31 | 181.00 | $-2.80 | 0.00 |
| 2020-12-31 | 141.60 | $-2.52 | 0.00 |
| 2020-09-30 | 124.68 | $-0.82 | 0.00 |
| 2020-06-30 | 89.31 | $-0.56 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.718B | $0.619B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $5.669B | 176.81 |
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |